ADC

Lotte Outlines Plans to Become Major CDMO Player

Lotte Biologics, part of South Korean conglomerate Lotte, has detailed expansions plans for the business as it embarks on a path to become a top 10 CDMO by 2030.

Merck Germany Doubles HPAPI Potential

The Life Science business segment of German pharmaceuticals, chemicals and life sciences group Merck has widened its US plant for high-potent active pharmaceutical ingredients (HPAPIs) at Verona, near Madison, Wisconsin to 6,500 m2.

The Rise of HPAPI Molecules

For biopharma leaders it is more critical than ever to secure the capabilities to contain, handle, develop and manufacture highly potent APIs.

ADC Bio to Invest $11m on Bioconjugation Facility

The Winning Formula

The Winning Formula

Catalent Acquires Micron Technologies

Merck Serono and Mersana Collaborate on Antibody Drug Conjugates

Fujifilm Diosynth Biotechnologies, Piramal Announce Strategic Alliance

Manufacturing of HPAPIs and ADC Toxins for the Drugs of Tomorrow